About
Daniele Reverberi serves as a Contract Professor in the Department of Experimental Medicine (DIMES) at the University of Genoa, with primary operational base at IRCCS San Martino Polyclinic Hospital in Genoa. He teaches Applied Medical Technical Sciences for the Biomedical Laboratory Techniques Degree Course (2024-2025), conducting student consultations from the Molecular Pathology Unit (Hall 90, IST-North, Tower C/4) and Clinical Risk Management offices.
His research centers on extracellular vesicles (EVs), with dual focus on methodological refinement and therapeutic applications. Key initiatives include optimizing flow cytometry sorting of plasma-derived EVs, developing copper-free click chemistry for EV functionalization in drug delivery, and investigating iPSC-derived mesenchymal stromal cell EVs for osteoarthritis treatment. A parallel oncology stream explores metabolic interventions where cyclic fasting enhances cholesterol biosynthesis inhibitors' anticancer efficacy.
Recent publications (2023-2025) reveal a cohesive trajectory bridging EV engineering and disease-specific therapeutic validation. The work spans technical standardization (isolation protocols, functionalization methods), disease modeling (osteoarthritis, cancer), and combinatorial therapy approaches, demonstrating consistent innovation in EV-based biomedical solutions across regenerative medicine and oncology domains.
Dr. Reverberi operates within the Molecular Pathology Unit infrastructure at San Martino Hospital, where laboratory facilities support his extracellular vesicle characterization, functionalization, and therapeutic efficacy testing pipelines for both regenerative and oncological applications.
